Skip to main content

METROPOLIS · Metropolis Healthcare Limited · Documents

563.60 INR -1.60 (-0.28%) At close · Nov 13
Volume · Nov 13 11.15K Avg daily vol (3M) 36.61K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Nov 4, 2026
2026
Nov 4
Earnings call
Revenue growth reaches 16.2% as EBITDA margin expands to 26.2%

Metropolis Healthcare reported first-half revenue growth of 16.2% and EBITDA margin expansion of 190 basis points to 26.2%, without price increases. Quarterly PAT grew 43% to INR75 crores, and the company declared an interim dividend of INR1 per share.

4 source passages
Importantly, we have delivered the step-up in growth while expanding EBITDA margins by 190 basis points to 26.2% EBITDA margin for the first half, and this is without any price increase so far in the year. For the first half as a whole, revenue grew by 16.2%, a clear step-up from 12% to 13% we have delivered in recent years, while margin expanded by 190 bps to 26.2%, reflecting the operating leverage in our business. PAT stood at INR75 crores, growing at 43% year-on-year. But before that, I just want to announce that the company has declared an interim dividend of INR1 per share. Open the document at this passage
Showing 1–3 of 3 documents